论文部分内容阅读
《中国临床研究》2016年8月第29卷第8期第1050页至1053页刊登的“CD163在肝癌术后肝衰竭患者中的表达及其与患者预后的关系”(作者:杨立学,陈科济,尉公田;单位:第二军医大学附属东方肝胆外科医院肝外二科,上海200438)一文,因作者本人投稿及定稿确认时均遗漏通讯作者信息,现予以补充及更正如下:(1)文章作者署名更正为:杨立学,陈科济,孙延富,尉公田(2)补充通讯作者:孙延富,E-mail:[email protected]
“Chinese clinical research” in August 2016, Vol. 29 No. 8, pp. 1050-1053 published “CD163 expression and its relationship with prognosis in patients after liver failure and liver cancer in the ” (Author: Raymond Young, science, Chen Keji, Wei Gongtian; Department of Hepatology, Second Affiliated Hospital, Second Military Medical University, Shanghai 200438, China) Due to the omission of authors’ information in the author’s submission and final confirmation, the following is added and corrected: 1) The authors signed corrected to: Mr Young study, Chen Ke Ji, Sun Yanfu, Wei public land (2) supplementary Corresponding author: Sun Yanfu, E-mail: [email protected]